Results for tag: "Plant Based Hemostat Powder"

Within the context of wound care, the plant-based hemostat powder market comprises a range of products aimed at promoting rapid blood coagulation and wound healing. These powders are derived from botanical sources and are used to control bleeding in various medical and surgical scenarios, including dental procedures, trauma, and surgery. Plant-based hemostatic agents are favored in certain clinical settings due to their biocompatibility and reduced risk of causing adverse reactions compared to synthetic or animal-derived products. They work by accelerating the body's natural coagulation processes or by providing a mechanical matrix that facilitates clot formation. As advancements in biotechnology and an increasing preference for natural medical products continue, the development and utilization of plant-based hemostatic powders in wound care are expected to evolve. Some companies active in the plant-based hemostat powder market include CR Bard, which is a subsidiary of Becton, Dickinson and Company, Ethicon (part of Johnson & Johnson), Pfizer, which acquired King Pharmaceuticals, and Anika Therapeutics, Inc. These companies are engaged in the research, development, and commercialization of various hemostatic products aimed at improving patient care in the field of wound management. Show Less Read more